** Drugmaker Karyopharm Therapeutics' shares KPTI.O down 15.8% at $4.21 premarket
** Company says in an SEC filing it is reducing its workforce by 20%
** Company expects its one-time expenses in connection with these actions to be immaterial
** Co says board is evaluating financing and strategic alternatives
** As of last close, stock down 50.7% YTD